Source: http://feedproxy.google.com/~r/mnt/healthnews/~3/wNAahFTIZlI/261013.php
Monday, 27 May 2013
Intensified, Liposomal Anthracycline-Based Chemo Regimen For Children With Leukemia May Offer High Survival Rates Without Added Heart Toxicity
Treating pediatric leukemia patients with a liposomal formulation of anthracycline-based chemotherapy at a more intense-than-standard dose during initial treatment may result in high survival rates without causing any added heart toxicity, according to the results of a study published online today in Blood, the Journal of the American Society of Hematology (ASH)...
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment